During the past decade, at Division of Endocrinology, the Affiliated Drum Tower Hospital of Nanjing University conducted 16 clinical trials. In the 10-year time frame, 16 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "at Division of Endocrinology, the Affiliated Drum Tower Hospital of Nanjing University" #1 collaborator was "The First Affiliated Hospital with Nanjing Medical University" with 2 trials as a collaborator, "Wuxi People's Hospital" with 2 trials as a collaborator, "Changzhou No.2 People's Hospital" with 1 trials as a collaborator, "Huai'an First People's Hospital" with 1 trials as a collaborator and "Nanjing PLA General Hospital" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 9 trials.

According to Clinical.Site data, the most researched conditions in "at Division of Endocrinology, the Affiliated Drum Tower Hospital of Nanjing University" are "Obesity" (4 trials), "Cognitive Impairment" (3 trials), "Non-Alcoholic Fatty Liver Disease" (3 trials), "Type 2 Diabetes" (3 trials) and "Type 2 Diabetes Mellitus" (3 trials). Many other conditions were trialed in "at Division of Endocrinology, the Affiliated Drum Tower Hospital of Nanjing University" in a lesser frequency.

Most popular intervention types in "at Division of Endocrinology, the Affiliated Drum Tower Hospital of Nanjing University" are "Drug" (8 trials), "Other" (4 trials), "Device" (2 trials), "Procedure" (2 trials) and "Behavioral" (1 trials). Other intervention types were less common.

The name of intervention was led by "Liraglutide" (2 trials), "Metformin" (2 trials), "1. Metformin tablets; 2. ProMetS probiotics powder" (1 trials), "10-year ASCVD risk estimation" (1 trials) and "Acarbose" (1 trials). Other intervention names were less common.

The vast majority of trials in "at Division of Endocrinology, the Affiliated Drum Tower Hospital of Nanjing University" are 15 trials for "All" genders and 2 trials for "Female" genders.

Currently, there are NaN active trials in "at Division of Endocrinology, the Affiliated Drum Tower Hospital of Nanjing University". undefined are not yet recruiting, 3 are recruiting, undefined are Active, not recruiting, and 3 are Enrolling by invitation. In total, there were 6 completed trials in at Division of Endocrinology, the Affiliated Drum Tower Hospital of Nanjing University, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in at Division of Endocrinology, the Affiliated Drum Tower Hospital of Nanjing University, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 4 trials, and there were also 4 trials that are defined as “Not Applicable".

at Division of Endocrinology, the Affiliated Drum Tower Hospital of Nanjing University has several departments that took part in Clinical trials: "Nanjing Drum Tower Hospital The Affiliated Hospital of Nanjing University Medical School-Oncology (" - 2 trials